The emergence of dual-action receptor agonists in the management of type 2 diabetes and obesity has sparked considerable focus, particularly regarding retatrutide and tirzepatide. While both medications target both the https://tasneemnynd941920.blogsvirals.com/37688542/retatrutide-vs-tirzepatide-a-comparative-analysis